The reduction in the number of repeats in FSHD patients abolishes this binding and results in the loosening of the transcriptional repression at 4q region and in the overexpression of upstream genes (FRG2, FRG1, ANT1) [28,29]. The gene discussed is FRG1; the disease is facioscapulohumeral muscular dystrophy.